Innovent Announces First Participant Dosed in the Higher-dose Cohort of a Phase 2 Clinical Trial of Mazdutide in Chinese Adults with Obesity ...Middle East

ROCKVILLE, Md. and SUZHOU, China, Sept. 4, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Announces First Participant Dosed in the Higher-dose Cohort of a Phase 2 Clinical Trial of Mazdutide in Chinese Adults with Obesity )

Also on site :

• ‘This is murder': Family remembers victims killed in Austin fire as 4th body recovered
• Diamondbacks Outright Aramis Garcia
• SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, NVEE, SOAR, PLL on Behalf of Shareholders